Back
Nuveen New York Municipal Value Fund Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
3
NNY
Nuveen New York Municipal Value Fund
Last Price:
8.40
Seasonality Move:
0.2%
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
259.70
Seasonality Move:
31.67%
Sell
3
Nuveen New York Municipal Value Fund (NNY)
is a Sell
Is Nuveen New York Municipal Value Fund a Buy, Sell or Hold?
- The current Nuveen New York Municipal Value Fund [NNY] share price is $8.42. The Score for NNY is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
- NNY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NNY Stock Price Chart
What is Nuveen New York Municipal Value Fund's stock price today?
-
The Nuveen New York Municipal Value Fund share price today is $8.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NNY is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $259.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 36.81 | Sell |
Chaikin Money Flow: | 6804 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.44 - 8.58) | Sell |
Bollinger Bands (100): | (8.33 - 8.55) | Sell |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 74.74 | Buy |
Chaikin Money Flow: | 898979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (203.29 - 223.91) | Buy |
Bollinger Bands (100): | (221.8 - 277.54) | Buy |
NNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.43 | Sell |
20-day SMA: | 8.49 | Sell |
50-day SMA: | 8.52 | Sell |
200-day SMA: | 8.36 | Buy |
8-day EMA: | 8.43 | Sell |
20-day EMA: | 8.47 | Sell |
50-day EMA: | 8.49 | Sell |
200-day EMA: | 8.39 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 216.22 | Buy |
20-day SMA: | 214.16 | Buy |
50-day SMA: | 227.04 | Buy |
200-day SMA: | 240.71 | Buy |
8-day EMA: | 223.2 | Buy |
20-day EMA: | 218.42 | Buy |
50-day EMA: | 226.38 | Buy |
200-day EMA: | 233.63 | Buy |
Nuveen New York Municipal Value Fund Earnings Growth & NNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.
Nuveen New York Municipal Value Fund Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |